QED Therapeutics

QED Therapeutics is a biotechnology company focused on developing precision therapies for rare genetic diseases, particularly those affecting the RAS/MAPK pathway. My knowledge indicates it's a specialized biotech firm with a clear scientific focus, but it appears to have limited mainstream visibility outside of specific medical and investment communities. The brand has moderate AI visibility within its niche biopharmaceutical market, with stronger understanding of its scientific mission than broad recognition or extensive content coverage.